Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells

被引:20
作者
Zhu, Lei [1 ]
Huang, Feizhou [1 ]
Deng, Gang [1 ]
Nie, Wanpin [1 ]
Huang, Wei [1 ]
Xu, Hongbo [1 ]
Zheng, Shaopeng [1 ]
Yi, Zhongjie [1 ]
Wan, Tao [1 ]
机构
[1] Cent South Univ, Xiangya Hosp 3, Dept Hepatobiliary & Pancreat Surg, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
关键词
intrahepatic cholangiocarcinoma; Sal-like protein 4; PTEN; Bmi-1; metastasis; EMT; EPITHELIAL-MESENCHYMAL TRANSITION; MYELOID-LEUKEMIA; EXPRESSION; BMI-1; TARGET; GENE; PROGNOSIS; UTILITY; PTEN;
D O I
10.2147/OTT.S107214
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In spite of improvements in surgical technology, the resectability and curability of intrahepatic cholangiocarcinoma (ICC) are still low. Our previous study showed that the strong Sal-like protein 4 (Sall4)-positive cases had shorter overall survival compared to Sall4-negative cases, indicating an oncogenic role of Sall4 in ICC. In this study, we aimed to explore the precise mechanism of Sall4 on ICC cell invasion and metastasis. We evaluated the expression of Sall4, PTEN, and Bmi-1 in 28 cases of adjacent tissues and 175 cases of ICC tissues by using immunohistochemical staining. We found that the expression of Sall4 and Bmi-1 was significantly increased in ICC tissues compared with the adjacent tissues, while PTEN expression was reduced in ICC tissues compared with the adjacent tissues, and there was a reverse relationship between Sall4 and PTEN in ICC, whereas there was a positive correlation in Sall4 and Bmi-1 expression in ICC. In addition, overall survival analysis showed that ICC patients with low PTEN exhibited a worse prognosis than ICC patients with high PTEN, and lower Bmi-1 expression showed a better prognosis than ICC patients with high Bmi-1. By a battery of experiments in vitro, we demonstrated that Sall4 promotes ICC cell proliferation, and progression of ICC might be through PTEN/PI3K/Akt and Bmi-1/Wnt/beta-catenin signaling and enhancing epithelial-mesenchymal transition process. Thus, Sall4 may be a potential target for the treatment of ICC metastasis.
引用
收藏
页码:5297 / 5305
页数:9
相关论文
共 28 条
[1]   Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis [J].
Al-Adra, D. P. ;
Gill, R. S. ;
Axford, S. J. ;
Shi, X. ;
Kneteman, N. ;
Liau, S. -S. .
EJSO, 2015, 41 (01) :120-127
[2]   Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma [J].
Chen, Ming-Huang ;
Chiang, Kun-Chun ;
Cheng, Chi-Tung ;
Huang, Shih-Chiang ;
Chen, Yeng-Yang ;
Chen, Tsung-Wen ;
Yeh, Ta-Sen ;
Jan, Yi-Yin ;
Wang, Hsi-Ming ;
Weng, Jiang-Jie ;
Chang, Peter Mu-Hsin ;
Liu, Chun-Yu ;
Li, Chung-Pin ;
Chao, Yee ;
Chen, Ming-Han ;
Huang, Chi-Ying F. ;
Yeh, Chun-Nan .
ONCOTARGET, 2014, 5 (09) :2372-2389
[3]   Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis [J].
Cillo, Umberto ;
Spolverato, Gaya ;
Vitale, Alessandro ;
Ejaz, Aslam ;
Lonardi, Sara ;
Cosgrove, David ;
Pawlik, Timothy M. .
WORLD JOURNAL OF SURGERY, 2015, 39 (10) :2500-2509
[4]   A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity [J].
Conde-Perez, Alejandro ;
Gros, Gwendoline ;
Longvert, Christine ;
Pedersen, Malin ;
Petit, Valerie ;
Aktary, Zackie ;
Viros, Amaya ;
Gesbert, Franck ;
Delmas, Veronique ;
Rambow, Florian ;
Bastian, Boris C. ;
Campbell, Andrew D. ;
Colombo, Sophie ;
Puig, Isabel ;
Bellacosa, Alfonso ;
Sansom, Owen ;
Marais, Richard ;
Van Kempen, Leon C. L. T. ;
Larue, Lionel .
NATURE COMMUNICATIONS, 2015, 6
[5]   SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma [J].
Deng, Gang ;
Zhu, Lei ;
Huang, Feizhou ;
Nie, Wanpin ;
Huang, Wei ;
Xu, Hongbo ;
Zheng, Shaopeng ;
Yi, Zhongjie ;
Wan, Tao .
ONCOTARGET, 2015, 6 (29) :27416-27426
[6]   Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma [J].
Gu, Mi Jin ;
Choi, Joon Hyuk .
JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (03) :229-234
[7]   Comprehensive Multiple Molecular Profile of Epithelial Mesenchymal Transition in Intrahepatic Cholangiocarcinoma Patients [J].
Huang, Xiao-Yong ;
Zhang, Chi ;
Cai, Jia-Bin ;
Shi, Guo-Ming ;
Ke, Ai-Wu ;
Dong, Zhao-Ru ;
Zhang, Peng-Fei ;
Fan, Jia ;
Peng, Bao-Gang ;
Zhou, Jian .
PLOS ONE, 2014, 9 (05)
[8]   Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management [J].
Lafaro, Kelly J. ;
Cosgrove, David ;
Geschwind, Jean-Francois H. ;
Kamel, Ihab ;
Herman, Joseph M. ;
Pawlik, Timothy M. .
GASTROENTEROLOGY RESEARCH AND PRACTICE, 2015, 2015
[9]   The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas [J].
Lee, Dakeun ;
Do, In-Gu ;
Choi, Kyusam ;
Sung, Chang Ohk ;
Jang, Kee-Taek ;
Choi, Dongwook ;
Heo, Jin Seok ;
Choi, Seoung Ho ;
Kim, Jongmin ;
Park, Jin Young ;
Cha, Hyung Jin ;
Joh, Jae-Won ;
Choi, Kwan Yong ;
Kim, Dae Shick .
MODERN PATHOLOGY, 2012, 25 (01) :131-139
[10]  
LEVY LS, 1993, ONCOGENE, V8, P1833